Hold Maintained at 1.5% Cap; Overweight-Ready Framework on Breakout/Capitulation Triggers
Hold maintained at 1.5% cap (not 2%) for the 9th consecutive iteration of this signal configuration. The pattern database is dispositive against escalation (+0.5% to -0.9% alpha across 8 Hold calls), the forward P/E of 22.8x on normalized EPS is binding (vs 44% earnings normalization from TTM), and AAPL+GOOGL+Amex concentration exceeds 50% of equity book. The constructive tactical view (RSI reset to 51, $4.21B Q2 buybacks, $18B carry on $366B cash, Abel's $31B deployment acceleration) is expressed through execution framework, not rating upgrade. Rating upgrades to Overweight only on confirmed breakout above $513 with MACD histogram expansion on 5M+ volume — the discipline is confirmation first, then rating, then size.
| Position | Action |
|---|---|
| Default (maintain position) | Maintain current weight with strict 1.5% portfolio cap (tightened from 2% per 8/26 concentration lesson) |
| Capitulation below $497 with volume >4M and 200 SMA holds | Staged adds: 30% at $498.50, 15% at $495-497, 15% at $492-494, targeting 1.0-1.25x benchmark weight |
| Breakout above $513 with volume >5M and MACD histogram expanding | Upgrade to Overweight; deploy 1.0-1.25x in tranches at $514, $518-522, $528-530 |
| Rallies to upper range ($515 upper Bollinger band) | Trim 10-20% reduction scaling into $524-529 zone (August swing high) |
BRK-B's P/B below 1.0x, $366B cash war chest, and coiled technical setup with MACD bullish crossover create an asymmetric long setup in a macro environment structurally tailored for Berkshire's defensive cash-flow profile.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 51.57 | neutral |
| MACD Line | 0.36 | bullish |
| MACD Signal | 0.34 | neutral |
| MACD Histogram | +0.02 | bullish |
| 10 EMA | 505.14 | neutral |
| 50 SMA | 503.29 | bullish |
| 200 SMA | 492.42 | bullish |
| Bollinger Upper Band | 513.40 | neutral |
| Bollinger Middle Band (20 SMA) | 504.23 | neutral |
| Bollinger Lower Band | 495.07 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $497 print with volume >4M AND 200 SMA holds
Then: Staged adds targeting 1.0-1.25x benchmark weight
↩ rebuts: “Momentum is broken; 50 SMA barely holding”
EV: +4.7–11%+ to $513-$560+ on breakout vs. -2.7% to 200 SMA at $492.42 · concedes: Forward P/E of 22.8 is elevated on a reported basis, though explained by TTM investment gain normalization rather than operational deterioration; Conglomerate discount remains a narrative risk that could persist if capital deployment is perceived as slow; 53.6% concentration in 4 names creates idiosyncratic exposure to those holdings; Post-earnings 3% drift over 30 days is real price action, though framed as noise rather than signal
BRK-B is a mediocre conglomerate trading at a growth premium (22.8x forward P/E) for a value business, with a $366B cash pile that signals deal scarcity rather than opportunity, a flatlining MACD suggesting distribution, and unpriced tail risk from succession uncertainty and concentration in mega-cap tech.
EV: -$420–$450 (bearish scenario over 12–18 months) · concedes: P/B below 1 does represent a mathematical discount to book value if book is trustworthy; The $366B cash pile does earn 5% in T-bills, providing some yield contribution; Greg Abel has strong operational credentials at BHE; Insurance segment has shown strong combined ratios recently
→ vs conservative: Valuation concerns (22.8x forward P/E, PEG 4-5) are category error ignoring $18B in zero-beta carry income; P/B below 1.0 conglomerate discount is misread as permanent when it will mean-revert with Abel's capital deployment
→ vs neutral: Waiting for confirmation above $513.40 or pullback below $492 is 'momentum chasing in reverse'; coiled spring technical setup (volatility compression, RSI reset, MACD bullish) is misread as 'no signal' when it historically resolves in direction of prevailing trend
| 6.07 |
| neutral |
Support: 492.42 · 495.07 · 500.7 | Resistance: 504.23 · 513.4 · 524.61 · 529.42
Intact medium-term uptrend in a low-volatility consolidation phase. The bullish MA stack (10 EMA > 50 SMA > 200 SMA) is intact with no death-cross risk. Momentum has healthily reset from August overbought extremes (RSI 74.55, MACD +8.38) to neutral territory. A fresh MACD bullish cross and contracting Bollinger Bands (squeeze from 8.53 to 6.07 ATR) suggest the next directional leg may be imminent to the upside. Upside objectives are $513.40 (upper band) and $524–530 (August highs); downside risk is contained while price holds above the 200 SMA at $492.42.
Market Cap
$1,082.84 B
P/E (TTM)
12.72
Forward P/E
22.79
P/B
0.97
PEG
10.06
EPS (TTM)
$39.77
Forward EPS
$22.19
Revenue (TTM)
$384.69 B
Gross Profit (TTM)
$116.68 B
EBITDA (TTM)
$130.68 B
Net Income (TTM)
$85.77 B
Operating Margin
32.56%
Profit Margin
22.30%
ROE
12.12%
ROA
6.01%
Beta
0.60
52-Week Range
$464.01 – $537.74
50-Day MA
$503.15
200-Day MA
$492.41
Debt/Equity
17.14
Current Ratio
2.89
Free Cash Flow (TTM)
$71.98 B
Total Assets
$1,263.07 B
Total Equity
$747.91 B
Total Debt
$128.60 B
Cash & ST Investments
$365.51 B
Equity Investments
$323.78 B
Insurance Float
~$170B+
Q2 2026 Revenue
$117.89 B
Q2 2026 Net Income
$25.77 B
Q2 2026 EPS
$11.91
Q2 2026 Buybacks
$4.21 B
Q2 2026 Interest Income
$5.86 B
Strengths
Concerns
HOLD
Macro: Fed rate cuts 2026 priced at ZERO (93% probability on Polymarket, $8.2M volume). Iran conflict escalating with surging oil prices pushing equities lower. US recession by end-2026 priced at just 8% — soft landing baseline dominates. Dow broke support intraday; defensive sectors outperforming. Silver above $66 driven by Iran premium.